FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2514348675> ?p ?o ?g. }

• W2514348675 endingPage "3477" @default.
• W2514348675 startingPage "3468" @default.
• W2514348675 abstract "A synergy between the polymer biomaterial and drug plays an important role in enhancing the therapeutic efficacy, improving the drug stability, and minimizing the local immune responses in the development of drug delivery systems. Particularly, in the case of ocular drug delivery, the need for the development of synergistic drug delivery system becomes more pronounced because of the wet ocular mucosal surface and highly innervated cornea, which elicit a strong inflammatory response to the instilled drug formulations. This article presents the development of a synergistic cysteamine delivery nanowafer to treat corneal cystinosis. Corneal cystinosis is a rare metabolic disease that causes the accumulation of cystine crystals in the cornea resulting in corneal opacity and loss of vision. It is treated with topical cysteamine (Cys) eye drops that need to be instilled 6-12 times a day throughout the patient's life, which causes side effects such as eye pain, redness, and ocular inflammation. As a result, compliance and treatment outcomes are severely compromised. To surmount these issues, we have developed a clinically translatable Cys nanowafer (Cys-NW) that can be simply applied on the eye with a fingertip. During the course of the drug release, Cys-NW slowly dissolves and fades away. The in vivo studies in cystinosin knockout mice demonstrated twice the therapeutic efficacy of Cys-NW containing 10 μg of Cys administered once a day, compared to 44 μg of Cys as topical eye drops administered twice a day. Furthermore, Cys-NW stabilizes Cys for up to four months at room temperature compared to topical Cys eye drops that need to be frozen or refrigerated and still remain active for only 1 week. The Cys-NW, because of its enhanced therapeutic efficacy, safety profile, and extended drug stability at room temperature, can be rapidly translated to the clinic for human trials." @default.
• W2514348675 created "2016-09-16" @default.
• W2514348675 creator A5021635738 @default.
• W2514348675 creator A5027567620 @default.
• W2514348675 creator A5035212343 @default.
• W2514348675 creator A5039412958 @default.
• W2514348675 creator A5052807762 @default.
• W2514348675 creator A5057446400 @default.
• W2514348675 creator A5080966543 @default.
• W2514348675 creator A5081844561 @default.
• W2514348675 creator A5086607086 @default.
• W2514348675 creator A5091379270 @default.
• W2514348675 date "2016-09-07" @default.
• W2514348675 modified "2023-10-12" @default.
• W2514348675 title "Synergistic Cysteamine Delivery Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis" @default.
• W2514348675 cites W136352482 @default.
• W2514348675 cites W1563147417 @default.
• W2514348675 cites W1969373623 @default.
• W2514348675 cites W1987828394 @default.
• W2514348675 cites W1992215904 @default.
• W2514348675 cites W1992495439 @default.
• W2514348675 cites W1993748822 @default.
• W2514348675 cites W2005293394 @default.
• W2514348675 cites W2009091430 @default.
• W2514348675 cites W2010723976 @default.
• W2514348675 cites W2012412619 @default.
• W2514348675 cites W2029558825 @default.
• W2514348675 cites W2031025032 @default.
• W2514348675 cites W2032250086 @default.
• W2514348675 cites W2045186887 @default.
• W2514348675 cites W2046762529 @default.
• W2514348675 cites W2055570027 @default.
• W2514348675 cites W2058230257 @default.
• W2514348675 cites W2058722090 @default.
• W2514348675 cites W2072176078 @default.
• W2514348675 cites W2074972505 @default.
• W2514348675 cites W2077648174 @default.
• W2514348675 cites W2085204896 @default.
• W2514348675 cites W2085905503 @default.
• W2514348675 cites W2095234402 @default.
• W2514348675 cites W2095805080 @default.
• W2514348675 cites W2108409199 @default.
• W2514348675 cites W2113746307 @default.
• W2514348675 cites W2123119954 @default.
• W2514348675 cites W2129431680 @default.
• W2514348675 cites W2136843236 @default.
• W2514348675 cites W2152024553 @default.
• W2514348675 cites W2156895262 @default.
• W2514348675 cites W2166434963 @default.
• W2514348675 cites W2166467743 @default.
• W2514348675 cites W2403337511 @default.
• W2514348675 cites W2408046718 @default.
• W2514348675 cites W2420388034 @default.
• W2514348675 cites W919615664 @default.
• W2514348675 doi "https://doi.org/10.1021/acs.molpharmaceut.6b00488" @default.
• W2514348675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27571217" @default.
• W2514348675 hasPublicationYear "2016" @default.
• W2514348675 type Work @default.
• W2514348675 sameAs 2514348675 @default.
• W2514348675 citedByCount "25" @default.
• W2514348675 countsByYear W25143486752017 @default.
• W2514348675 countsByYear W25143486752018 @default.
• W2514348675 countsByYear W25143486752019 @default.
• W2514348675 countsByYear W25143486752020 @default.
• W2514348675 countsByYear W25143486752021 @default.
• W2514348675 countsByYear W25143486752022 @default.
• W2514348675 countsByYear W25143486752023 @default.
• W2514348675 crossrefType "journal-article" @default.
• W2514348675 hasAuthorship W2514348675A5021635738 @default.
• W2514348675 hasAuthorship W2514348675A5027567620 @default.
• W2514348675 hasAuthorship W2514348675A5035212343 @default.
• W2514348675 hasAuthorship W2514348675A5039412958 @default.
• W2514348675 hasAuthorship W2514348675A5052807762 @default.
• W2514348675 hasAuthorship W2514348675A5057446400 @default.
• W2514348675 hasAuthorship W2514348675A5080966543 @default.
• W2514348675 hasAuthorship W2514348675A5081844561 @default.
• W2514348675 hasAuthorship W2514348675A5086607086 @default.
• W2514348675 hasAuthorship W2514348675A5091379270 @default.
• W2514348675 hasConcept C118487528 @default.
• W2514348675 hasConcept C126322002 @default.
• W2514348675 hasConcept C150903083 @default.
• W2514348675 hasConcept C178790620 @default.
• W2514348675 hasConcept C181199279 @default.
• W2514348675 hasConcept C185592680 @default.
• W2514348675 hasConcept C207001950 @default.
• W2514348675 hasConcept C2776609658 @default.
• W2514348675 hasConcept C2776882836 @default.
• W2514348675 hasConcept C2777608289 @default.
• W2514348675 hasConcept C2778518273 @default.
• W2514348675 hasConcept C2779201268 @default.
• W2514348675 hasConcept C2779820397 @default.
• W2514348675 hasConcept C2780035454 @default.
• W2514348675 hasConcept C55493867 @default.
• W2514348675 hasConcept C71924100 @default.
• W2514348675 hasConcept C86803240 @default.
• W2514348675 hasConcept C98274493 @default.
• W2514348675 hasConceptScore W2514348675C118487528 @default.
• W2514348675 hasConceptScore W2514348675C126322002 @default.

• next